logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Cera Sanitaryware Navigates Q3 FY26 with Growth Amidst Margin Pressures

CERA

Cera Sanitaryware Ltd

CERA

Ask AI

Ask AI

Cera Sanitaryware Limited, a prominent player in India's sanitaryware market, reported its Q3 FY26 earnings, showcasing a period of healthy top-line growth alongside notable margin pressures. The company's revenue from operations for the quarter stood at INR 499 crore, marking an impressive 11.1% year-on-year growth. This performance indicates a sequential recovery and a steady strengthening trend in market conditions, reflecting Cera's improved market traction.

However, the quarter saw a contraction in profitability. EBITDA margins for Q3 FY26 were recorded at 10.2%, a decline from 13.2% in Q3 FY25. This dip was primarily attributed to an increase in trade discounts, particularly from higher participation in projects, and elevated brass input costs, which rose by approximately 12% during the quarter. Additionally, higher publicity expenditures and pre-operative costs associated with the launch of new brands, Senator and Polipluz, further weighed on the margins. Consequently, Profit After Tax (PAT) for the quarter significantly decreased to INR 24 crore, compared to INR 46 crore in the corresponding period of the previous year.

Financial Metric (INR Crore)Q3 FY25Q3 FY26YoY Growth (%)
Revenue from Operations44949911.1
EBITDA5951-13.6
EBITDA Margin (%)13.210.2-300 bps
PAT4624-47.9
EPS (INR)35.5618.35-48.4

Strategic Initiatives and Market Traction

Cera Sanitaryware's management emphasized that the margin contraction in Q3 FY26 was largely a 'phasing impact' and not indicative of a long-term structural issue. To mitigate the impact of rising input costs, the company has proactively announced calibrated price increases: an average of 11% for Faucetware and 4% for Sanitaryware, effective March 1, 2026. This strategic move aims to balance margin protection with market competitiveness.

The company's core categories, Sanitaryware and Faucetware, collectively accounted for 88% of the total revenues in Q3 FY26. Sanitaryware revenue grew by 6.4%, Faucetware by 18.2%, Tiles by 5.7%, and Wellness by 29.4% year-on-year. From a product mix perspective, 44% of sales came from the premium segment, 35% from the mid-segment, and 21% from entry-level products. Geographically, Tier 3 cities emerged as a significant growth driver, contributing 41% of sales, followed by Tier 1 cities at 36% and Tier 2 cities at 23%. This highlights the company's expanding reach and market penetration beyond metropolitan areas.

Capacity utilization remained robust, with Faucetware operating at 102% and Sanitaryware at 82%, demonstrating efficient operational management despite market fluctuations. The company's strong brand equity, execution reliability, and long-standing relationships with developers continue to enable participation in larger and more complex projects, making this segment a crucial support pillar.

New Brand Development and Distribution Expansion

Cera is actively investing in its new brands, Senator and Polipluz, as key levers for its brand architecture. The Senator brand, positioned for luxury, is progressing with its flagship store rollout, with 32 stores currently operational. The company is adopting a calibrated approach to further expansion, focusing on sharpening per-store performance metrics. While initial sales projections for Senator and Polipluz for the current year were revised downwards from INR 40 crore to INR 20 crore due to store readiness, the management projects sales of INR 100-120 crore from these brands in the next financial year, indicating confidence in their long-term potential.

Polipluz, Cera's affordable bath solutions brand, is in its investment and buildup phase, targeting rural and semi-urban markets. The team buildup is largely complete, with a focus on strengthening distribution and market presence. Polipluz is currently distributed through 65 distributors and 750 dealers, bridging the value gap in India's underpenetrated rural markets.

Product SegmentRevenue Contribution (Q3 FY26)
Sanitaryware48%
Faucetware40%
Tiles10%
Wellness2%

Outlook and Financial Discipline

Despite the near-term consumption trends remaining uneven, Cera's management expressed confidence in a structural recovery, expecting the growth trajectory to be sustainable. The company anticipates ending FY26 with an overall full-year revenue growth of roughly 7-8% and maintaining double-digit growth in Q4 FY26 and the coming financial year. EBITDA margins are expected to recover to 13-14% in Q4 FY26 and potentially reach 16-17% in the second half of the next financial year.

Cera Sanitaryware maintains a robust financial position, characterized by a debt-free balance sheet and cash and cash equivalents of INR 757 crore as of December 31, 2025. The capital expenditure plan for FY26 remains measured at around INR 13.2 crore, primarily directed towards routine maintenance and selective investments in brand presence and retail initiatives. Capital allocation is guided by disciplined return visibility and a strong focus on maintaining balance sheet strength. The company's consistent dividend payout for over 30 years further underscores its financial prudence.

While the construction of a new Sanitaryware facility has been deferred, with a decision pending by Q4 FY26 based on market conditions, the company continues to enhance its operational efficiencies. Cera's commitment to environmental stewardship, social responsibility, and governance excellence is also evident through its ISO certifications and renewable energy initiatives. The company's strategic focus on innovation, distribution expansion, and disciplined financial management positions it well to capitalize on improving demand conditions and deliver sustainable long-term value.

Frequently Asked Questions

Cera Sanitaryware reported a revenue of INR 499 crore, marking an 11.1% year-on-year growth. However, EBITDA margins declined to 10.2% from 13.2% in Q3 FY25, and PAT decreased to INR 24 crore from INR 46 crore.
The decline in EBITDA margins was primarily due to increased trade discounts, elevated brass input costs (up by approximately 12%), higher publicity expenditures, and pre-operative costs for new brand launches like Senator and Polipluz.
Cera Sanitaryware has announced calibrated price increases, with Faucetware prices rising by over 11% and Sanitaryware by over 4%, effective March 1, 2026, to mitigate cost pressures and protect margins.
Senator has 32 operational flagship stores, and Polipluz is being distributed through 65 distributors and 750 dealers. While current year sales projections for these brands were revised downwards, management expects them to contribute INR 100-120 crore next financial year.
The company expects to end FY26 with 7-8% overall revenue growth and anticipates double-digit growth in Q4 FY26 and the next financial year. EBITDA margins are projected to recover to 13-14% in Q4 FY26 and potentially reach 16-17% in the second half of the next financial year.
Cera maintains a debt-free balance sheet with INR 757 crore in cash and equivalents. Capital allocation is guided by disciplined return visibility, with free cash flow comfortably covering dividend and reinvestment needs. The company has a consistent dividend payout history of over 30 years.

A NOTE FROM THE FOUNDER

Hey, I'm Aaditya, founder of Multibagg AI. If you enjoyed reading this article, you've only seen a small part of what's possible with Multibagg AI. Here's what you can do next:

It's all about thinking better as an investor. Welcome to a smarter way of doing stock market research.